222 related articles for article (PubMed ID: 33008919)
1. Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.
Nair PC; Chau N; McKinnon RA; Miners JO
Mol Pharmacol; 2020 Dec; 98(6):710-718. PubMed ID: 33008919
[TBL] [Abstract][Full Text] [Related]
2. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
3. The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.
Xiong Y; Patana AS; Miley MJ; Zielinska AK; Bratton SM; Miller GP; Goldman A; Finel M; Redinbo MR; Radominska-Pandya A
Drug Metab Dispos; 2008 Mar; 36(3):517-22. PubMed ID: 18048489
[TBL] [Abstract][Full Text] [Related]
4. Insights into the UDP-sugar selectivities of human UDP-glycosyltransferases (UGT): a molecular modeling perspective.
Nair PC; Meech R; Mackenzie PI; McKinnon RA; Miners JO
Drug Metab Rev; 2015 Aug; 47(3):335-45. PubMed ID: 26289097
[TBL] [Abstract][Full Text] [Related]
5. Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.
Battaglia E; Nowell S; Drake RR; Magdalou J; Fournel-Gigleux S; Senay C; Radominska A
Drug Metab Dispos; 1997 Apr; 25(4):406-11. PubMed ID: 9107538
[TBL] [Abstract][Full Text] [Related]
6. Drug and Chemical Glucosidation by Control Supersomes and Membranes from
Chau N; Kaya L; Lewis BC; Mackenzie PI; Miners JO
Drug Metab Dispos; 2019 Mar; 47(3):271-278. PubMed ID: 30541877
[TBL] [Abstract][Full Text] [Related]
7. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
8. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
9. The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues.
Ouzzine M; Gulberti S; Levoin N; Netter P; Magdalou J; Fournel-Gigleux S
J Biol Chem; 2002 Jul; 277(28):25439-45. PubMed ID: 11986319
[TBL] [Abstract][Full Text] [Related]
10. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.
Miley MJ; Zielinska AK; Keenan JE; Bratton SM; Radominska-Pandya A; Redinbo MR
J Mol Biol; 2007 Jun; 369(2):498-511. PubMed ID: 17442341
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
13. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
[TBL] [Abstract][Full Text] [Related]
14. The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution.
MacKenzie PI; Rogers A; Elliot DJ; Chau N; Hulin JA; Miners JO; Meech R
Mol Pharmacol; 2011 Mar; 79(3):472-8. PubMed ID: 21088224
[TBL] [Abstract][Full Text] [Related]
15. Glycosidation of an endothelin ET(A) receptor antagonist and diclofenac in human liver microsomes: aglycone-dependent UDP-sugar selectivity.
Tang C; Ma B
Drug Metab Dispos; 2005 Dec; 33(12):1796-802. PubMed ID: 16129696
[TBL] [Abstract][Full Text] [Related]
16. Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.
Meech R; Rogers A; Zhuang L; Lewis BC; Miners JO; Mackenzie PI
J Biol Chem; 2012 Jul; 287(29):24122-30. PubMed ID: 22621930
[TBL] [Abstract][Full Text] [Related]
17. SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases.
Ondo K; Arakawa H; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2020 May; 175():113916. PubMed ID: 32179043
[TBL] [Abstract][Full Text] [Related]
18. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
20. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]